Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case Related Posts Altech – Commences Selling Sodium Nickel Chloride Batteries September 30, 2025 Newmont Exits Orla Mining With US$439 Million Share... September 20, 2025 Blue Sky Uranium Acquires Key Subsurface Data for... July 3, 2025 Altech Batteries LtdNext Generation Cerenergy Battery Pack Achieves... September 23, 2025 CSE Bulletin: Suspension – Green River Gold Corp. April 2, 2025 Crypto Market Update: Altcoins Retreat as Bitcoin ETFs... October 11, 2025